The short version
8 companies supply this market — a reasonable cushion if one runs into trouble. The generic price is up 9% over the past year, to $5.05 per unit. The brand runs $13.07 per unit — 2.6× more.
Market view
alogliptin
27 marketed package NDCs · 8 active manufacturers
Most dispensed: BENZOATE 25 mg · Tablet, Film Coated · #30 tablet, film coateds/bottle · BENZOATE 12.5 mg · Tablet, Film Coated · #30 tablet, film coateds/bottle · BENZOATE 6.25 mg · Tablet, Film Coated · #30 tablet, film coateds/bottle
Price range and competition
RSS: changes for this drugpriced separately — they are not the same market
Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $5.05 · middle half $4.99–$5.12 · full range $4.92–$5.18 · 3 products · 8 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for alogliptin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- AlogliptinAug 19, 2026Price downNADAC $4.92805 → $4.92307 per unit (-0.1%)
- AlogliptinAug 19, 2026Price upNADAC $5.04993 → $5.0543 per unit (+0.09%)
- AlogliptinAug 19, 2026Price upNADAC $5.07004 → $5.18042 per unit (+2.18%)
- AlogliptinJul 22, 2026Price upNADAC $4.97764 → $5.04993 per unit (+1.45%)
- AlogliptinJul 22, 2026Price upNADAC $5.02476 → $5.07004 per unit (+0.9%)
- AlogliptinJul 22, 2026Price upNADAC $4.8534 → $4.92805 per unit (+1.54%)
Same drug class
Other molecules FDA puts in Dipeptidyl Peptidase 4 Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- alogliptin and pioglitazone· 1 maker
- empagliflozin and linagliptin· 1 maker
- empagliflozin, linagliptin, metformin hydrochloride· 1 maker
- saxagliptin and metformin· 1 maker
- saxagliptin and metformin hydrochloride· 1 maker
- sitagliptin hydrochloride oral· 1 maker
- alogliptin benzoate and pioglitazone hydrochloride· 2 makers
- ertugliflozin and sitagliptin· 2 makers
- linagliptin and metformin hydrochloride· 4 makers
- alogliptin and metformin hydrochloride· 5 makers
- saxagliptin· 6 makers
- sitagliptin· 10 makers
Common questions
- Is Alogliptin in shortage right now?
- No. FDA does not currently list Alogliptin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Alogliptin?
- 8 companies have marketed Alogliptin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Alogliptin cost?
- The typical pharmacy pays about $5.05 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.